Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Influence of Perfluorocarbon Liquid (LIQUID) During Pars Plana Vitrectomy on Retinal Vessel Displacement in Primary Macula-involving Rhegmatogenous Retinal Detachment [NA]

View source ↗

Summary

A clinical trial evaluating whether using perfluorocarbon liquid during pars plana vitrectomy affects retinal vessel displacement in primary macula-involving rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perfluorocarbon Liquid

Snippet

Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust | Conditions: Retinal Displacement After Retinal Detachment Surgery | NA | Status: RECRUITING